{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1010000781859428099.json","@type":"Article","resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"ja","@value":"分子シャペロンとAAA＋プロテアーゼの研究"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1030003658511123585","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60110342"},{"@type":"NRID","@value":"1000060110342"},{"@type":"NRID","@value":"9000006234592"}],"foaf:name":[{"@language":"ja","@value":"山本 友子"},{"@language":"en","@value":"Yamamoto Tomoko"}],"jpcoar:affiliationName":[{"@language":"ja","@value":"千葉大学"}]}],"publication":{"prism:publicationName":[{"@language":"ja","@value":"化学療法の領域"}],"prism:publicationDate":"2017","prism:volume":"33","prism:startingPage":"283","prism:endingPage":"290","jointInternationalResearch":"false"},"reviewed":"false","project":[{"@id":"https://cir.nii.ac.jp/crid/1040000781859428096","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"15K15128"},{"@type":"JGN","@value":"JP15K15128"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K15128/"}],"notation":[{"@language":"ja","@value":"難治性慢性感染症治療薬となるAnti-persister 化合物の探索研究"},{"@language":"en","@value":"Identification and development of anti-persister compounds as a new  class of antibiotics to treat chronic infection"}]}],"dataSourceIdentifier":[{"@type":"KAKEN","@value":"PRODUCT-21104078"}]}